Please assess the completion status of the following clinical trial:

Trial Title: Phase I, Open-label, Dose-escalation, Safety and PK Study of AZD4877

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Part A: Advanced solid tumors (including lymphoma without bone marrow involvement) for which standard treatment doesn't exist or is no longer effective.~* Part B: B-cell non-Hodgkin lymphoma that is not eligible for curative therapy or has relapsed.~* Relatively good overall health other than your cancer~Exclusion Criteria:~* Poor bone marrow function (not producing enough blood cells). Serious heart conditions. Poor liver or kidney function

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).